4/A//SEC Filing
Carter Laura 4/A
Accession 0001728117-22-000094
CIK 0001728117other
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 5:04 PM ET
Size
5.9 KB
Accession
0001728117-22-000094
Insider Transaction Report
Form 4/AAmended
Carter Laura
Chief Scientific Officer
Transactions
- Sale
Common Stock
2022-10-24$12.07/sh−4,876$58,868→ 82,292 total
Footnotes (3)
- [F1]The Reporting Person's purchase of 6,934 shares of common stock at a price of $7.21 per share on July 15, 2022 was matchable under Section 16(b) of the Securities Exchange Act of 1934, with the Reporting Person's sale of common stock reported herein and, to the extent of 2,058 shares, the Reporting Person's sale of common stock at a price of $8.278 per share on March 16, 2022. The Reporting Person has agreed top pay to the Issuer $18,558.51, which, together with the $7,351.42 previously paid to the Issuer on July 15, 2022, represents the full amount of the profit realized in connection with the short-swing transaction.
- [F2]Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
- [F3]This transaction was executed in multiple trades at prices ranging from $11.881 to $12.078 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold.Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Documents
Issuer
Gossamer Bio, Inc.
CIK 0001728117
Entity typeother
Related Parties
1- filerCIK 0001858178
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 26, 8:00 PM ET
- Accepted
- Oct 27, 5:04 PM ET
- Size
- 5.9 KB